Skip to main content

Your search for “Sanford Stem Cell Clinical Center” returned 95 results

$150 Million Gift Takes Stem Cell Research to New Heights

September 6, 2022

Noted businessman and philanthropist T. Denny Sanford has committed $150 million in new funding to expand and, in some ways, quite literally launch stem cell research and regenerative medicine at University of California San Diego into new spaces and endeavors.

Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice

January 20, 2021

UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.

Promise Put to the Test

October 20, 2014

UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve potential therapies for spinal cord injuries, Type 1 diabetes and chronic lymphocytic leukemia.

UC San Diego Receives $9 Million in Grants to Pinpoint Cellular Cause of Type 1 Diabetes

August 13, 2019

UC San Diego School of Medicine has been awarded $9 million to fund research projects using human pluripotent stem cells, CRISPR and human organoids to dissect beta cell defects and create a human cell model of type 1 diabetes aimed at identifying the cellular actions leading to disease onset.

Small Molecule Drug Reverses ADAR1-induced Cancer Stem Cell Cloning Capacity

February 16, 2023

UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.

23rd Annual Luau and Legends of Surfing Invitational Set for Aug. 21

August 10, 2016

…competition and festive luau. All proceeds benefit Moores Cancer Center at UC San Diego Health.

Transplanted Hematopoietic Stem Cells Reverse Damage Caused by Neuromuscular Disorder

October 25, 2017

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mouse model of Friedreich’s ataxia (FA) measurably halted cellular damage caused by the degenerative disease.

Researchers Find a New Way to Identify and Target Malignant Aging in Leukemia

August 26, 2016

…California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already experienced a bout with…

UC San Diego Nets Another Top Global Ranking

March 19, 2015

…has established its own Center for Brain Activity Mapping. The Qualcomm Institute for Telecommunications and Information Technology illustrates UC San Diego’s multidisciplinary approach. By leveraging strength in computer science, researchers have collaborated to extend the application of cutting-edge communications technology into diverse fields. Researchers at Scripps Institution of Oceanography at…

Newly Named Shiley Eye Institute Projects Bigger, Bolder Vision

February 11, 2015

…regional hub for unparalleled clinical care, research, education and community service, the UC San Diego Shiley Eye Center has been renamed the UC San Diego Donald P. and Darlene V. Shiley Eye Institute, encompassing the Shiley Eye Center, the Anne F. and Abraham Ratner Children’s Eye Center, the Hamilton Glaucoma…

Category navigation with Social links